Kidney Cancer Drugs Market- Asia Pacific To Register Highest CAGR
Magic 1065 is a press release distribution service. On Nov 26, 2019, it released an article on the Kidney Cancer Drugs Global Market, sourced from TBRC`S Kidney Cancer Drugs Global Market Report. Rise in incidence of renal cancer acts as one of the major drivers of the kidney cancer drugs market. Change in lifestyles of people, consumption of tobacco, and unhealthy diet are some factors which contribute to the growth of these renal cancer cells. According to the American Cancer Society Report 2018, an estimated 65,340 new cases of kidney (renal) cancer were diagnosed in the US in 2018. In 2014, the estimation was around 63,920 new cases. Thus, this is driving the growth of the kidney cancer drugs market. Increasing use of biologics and targeted therapies acts as a restraint for the kidney cancer drugs market.